binocrit
Sandoz receives EU approval for subcutaneous injection of Binocrit biosimilar
April 8, 2016Medical Communications, Research and Development Sandoz, binocrit, biosimilar, eu approval
Sandoz has received approval from the European Commission for a type II variation for the addition of a subcutaneous route …
Latest content
The evidence bar impacting UK medical cannabis access
November 6, 2026
Addressing the rheumatic disease diagnostic gap in primary care
November 5, 2026
